More than 150 years have elapsed since endometriosis was discovered and described. Yet, until now, no scholarly history has ever been written about the disease, which affects millions of women worldwide.
An announcement at the American Society of Clinical Oncology annual meeting that the drug exemestane significantly reduces the risk of breast cancer in high-risk, postmenopausal women is the result of a clinical trial in which UB researchers and women in Western New York played a critical role.
Glenna Bett, PhD, will use her Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation to develop a device that could reduce perinatal deaths worldwide.
